References
- Gray CFE. Concised Williams Obstetrics. New York: McGraw Hill; 2014
- Nigro G, Mazzocco M, Mattia E, et al. Role of the infections in recurrent spontaneous abortion. J Matern Fetal Neonatal Med 2011;24: 983–9
- Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004;363:1965–76
- Robert-Gangneux F, Dardé M-L. Epidemiology of and diagnostic strategies for toxoplasmosis. Clin Microbiol Rev 2012;25:264–96
- Dalimi A, Abdoli A. Latent toxoplasmosis and human. Iran J Parasitol 2012;7:1–17
- Paquet C, Yudin M. Toxoplasmosis in pregnancy: prevention, screening, and treatment. J Obstet Gynaecol Can 2013;35:78–9
- Li X-L, Wei H-X, Zhang H, et al. A meta analysis on risks of adverse pregnancy outcomes in Toxoplasma gondii infection. PLoS One 2014;9:e97775
- Abdoli A, Dalimi A, Arbabi M, Ghaffarifar F. Neuropsychiatric manifestations of latent toxoplasmosis on mothers and their offspring. J Matern Fetal Neonatal Med 2014;27:1368–74
- Abdoli A, Dalimi A. Are there any relationships between latent Toxoplasma gondii infection, testosterone elevation, and risk of autism spectrum disorder? Front Behav Neurosci 2014;8:339
- Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ 2013;91:501–8
- Daryani A, Sarvi S, Aarabi M, et al. Seroprevalence of Toxoplasma gondii in the Iranian general population: a systematic review and meta-analysis. Acta Trop 2014;137:185–94
- Borna S, Shariat M, Fallahi M, Janani L. Prevalence of immunity to toxoplasmosis among Iranian childbearing age women: systematic review and meta-analysis. Iran J Reprod Med 2013;11:861–8
- McLeod R, Lykins J, Noble AG, et al. Management of congenital toxoplasmosis. Curr Pediatr Rep 2014;2:166–94
- Abdul-Ghani R. Polymerase chain reaction in the diagnosis of congenital toxoplasmosis: more than two decades of development and evaluation. Parasitol Res 2011;108:505–12
- Hosseinzadeh M, Khosravi A, Shidelzadeh L, et al. Seroepidemiological assessment of toxoplasmosis in women with and without abortion in Islam. Health Serv Res 2011;6:626–34
- Homan W, Vercammen M, De Braekeleer J, Verschueren H. Identification of a 200-to 300-fold repetitive 529 bp DNA fragment in Toxoplasma gondii, and its use for diagnostic and quantitative PCR. Int J Parasitol 2000;30:69–75
- Aali bibi S, Fasihi Harandi M, Nazari E. Comparison of Toxoplasma gondii IgG and IgM seropositivity between women with spontaneous abortions and ongoing pregnancies. Iran J Obstet, Gyneocol Infertil 2011;14:1–6
- Jahromi A. Anti-Toxoplasma antibodies in women with a history of miscarriage or fetal death. J Jahrom Univ Med Sci 2008;4:47–52
- Sahwi SY, Zaki MS, Haiba NY, et al. Toxoplasmosis as a cause of repeated abortion. J Obstet Gynaecol 1995;21:145–8
- Qublan H, Jumaian N, Abu-Salem A, et al. Toxoplasmosis and habitual abortion. J Obstet Gynecol 2002;22:296–8
- Singh N. Status of toxoplasma antibodies in recurrent fetal loss in UAE women. Indian J Pediatr 1998;65:891–7
- Rasti S, Behrashi M, Kazemi B, et al. Diagnosis of congenital toxoplasmosis by polymerase chain reaction. Indian J Med Microbiol 2012;30:251
- El Fakahany A, Abdel-Maboud A, El-Garhy M, Eraky M. Comparative study between ELISA IgG, IgM and PCR in diagnosing and studying toxoplasmosis in Qualyobia Governorate, Egypt. J Egypt Soc Parasitol 2002;32:475–86
- Asgari Q, Fekri M, Monabati A, et al. Molecular genotyping of Toxoplasma gondii in human spontaneous aborted fetuses in Shiraz, Southern Iran. Iranian J Publ Health 2013;42:620–5
- Rasti S, Hooshyar H, Arbabi M, et al. Frequency of Toxoplasma Infection among pregnant women and their newborn in Kashan, Iran. ZJRMS 2015;17:32–5
- Cook A, Gilbert R, Buffolano W, et al. Sources of toxoplasma infection in pregnant women: European multicentre case–control study. Commentary: congenital toxoplasmosis – further thought for food. Br Med J 2000;321:142–7
- Boyer KM, Holfels E, Roizen N, et al. Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: implications for prenatal management and screening. Am J Obstet Gynecol 2005;192:564–71
- Sakikawa M, Noda S, Hanaoka M, et al. Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan. Clin Vac Immunol 2012;19:365–7